Small Molecules, Biosimilars & Therapeutic Targets
Age-related macular degeneration (AMD) affects 11 million people in the U.S. It occurs when aging causes damage to the macula, the part of the eye that controls straight-ahead vision. There are two types: dry AMD and wet AMD. Dry AMD is when the macula gets thinner with age, while wet AMD occurs when abnormal blood […]
Geographic Atrophy in AMD
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that affects the retina. Those with GA can have good vision if the macula, the center part of the retina responsible for sharp, central vision, isn’t damaged. While there are ways to assess the how well different therapies are working, visual acuity tests […]
AMD Research News
Age Related Macular Degeneration (AMD) is a vision condition that no one wants. As the name suggests, this affects persons over the age of 50. It comes about when the macula, the part of the retina that controls sharp, straight-ahead vision, becomes damaged over time. While it doesn’t lead to total blindness, losing central vision […]
Automation Comes to Eye Imaging
Aren’t optical coherence tomography (OCT) machines great? The machine uses light waves to take a cross-section of the retina and this allows the eye doctor to map and measure its thickness. These measurements help with the diagnosis and treatment of glaucoma, age-related macular degeneration (AMD) and diabetic eye disease. As great as an OCT machine […]
Treatment Options for Age Related Macular Degeneration
Age related macular degeneration (AMD) is the leading cause of vision loss in persons over the age of 50. If the person has the “wet” variety, treatments include anti–vascular endothelial growth factor (VEGF) drugs that are injected into the eye and laser treatments. The trouble comes when a person has AMD that is resistant to […]
Research
Thanks to biomedical research, our understanding of the human body is evolving and this has led to treatments that improve health outcomes. This includes vision research and as a result, more is being learned about what leads to amblyopia and a possible treatment for age-related macular degeneration (AMD). Amblyopia Amblyopia, also known as lazy eye, […]
Faulty Molecules Switches & Certain Genomic Regions Contribute to AMD
It is safe to say that no one wants to be blind. While age related macular degeneration (AMD) isn’t as well-known as glaucoma and cataracts, it, too, is a form a blindness that no one wants. It affects the straight on vision that is needed for activities like reading and driving and while medication can […]